Modulation of Philadelphia Chromosome-Positive Hematological Malignancies by the Bone Marrow Microenvironment

作者: Lin Wang , Heather O’Leary , Laura F. Gibson

DOI: 10.1007/978-1-4419-0711-0_18

关键词:

摘要: Hematological malignancies often have cytogenetically distinct chromosomal translocations, resulting in fusion proteins that lead to deregulation of specific signaling pathways and phenotypic outcomes. The constitutively active Bcr-Abl kinase defines the underlying cause for several forms leukemia humans. Due different breakpoints Bcr gene, reciprocal translocation between chromosomes 9 22 (the so-called Philadelphia chromosome (Ph+) (Nowell, 2007; Koretzky, 2007)) generates proto-oncoproteins variable size. p210 protein is predominantly associated with CML during chronic phase, but can also be detected acute lymphoblastic (ALL) blast transformation. In contrast, p185 most generation de novo B-lineage ALL, has been shown expressed rare cases T-cell mast cell as well endothelial cells derived from patients CML. While high, constitutive Abl activity thought driving force initiation progression leukemic disease, bone marrow microenvironment plays a pivotal role maintaining Ph+ stem cells. following chapter we discuss interplay expression microenvironment-derived cues their collective influence on leukemogenesis.

参考文章(200)
Harry Rubin, Microenvironmental regulation of the initiated cell. Advances in Cancer Research. ,vol. 90, pp. 1- 62 ,(2003) , 10.1016/S0065-230X(03)90001-7
Bernhard Schmierer, Caroline S. Hill, TGFβ–SMAD signal transduction: molecular specificity and functional flexibility Nature Reviews Molecular Cell Biology. ,vol. 8, pp. 970- 982 ,(2007) , 10.1038/NRM2297
Maria Cirinnà, Rossana Trotta, Paolo Salomoni, Plamen Kossev, Mariusz Wasik, Danilo Perrotti, Bruno Calabretta, Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation Blood. ,vol. 96, pp. 3915- 3921 ,(2000) , 10.1182/BLOOD.V96.12.3915.H8003915_3915_3921
Rik Derynck, Rosemary J. Akhurst, Allan Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. ,vol. 29, pp. 117- 129 ,(2001) , 10.1038/NG1001-117
Elisabetta Dejana, Endothelial cell-cell junctions: happy together. Nature Reviews Molecular Cell Biology. ,vol. 5, pp. 261- 270 ,(2004) , 10.1038/NRM1357
G Iotti, G Ferrari-Amorotti, C Rosafio, F Corradini, M R Lidonnici, M Ronchetti, M Bardini, Y Zhang, R Martinez, F Blasi, B Calabretta, Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells. Oncogene. ,vol. 26, pp. 3482- 3491 ,(2007) , 10.1038/SJ.ONC.1210146
Nora Heisterkamp, Jan Willem Voncken, Dinithi Senadheera, Ignacio Gonzalez-Gomez, Anja Reichert, Leena Haataja, Arja Reinikainen, Paul K. Pattengale, John Groffen, Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants. Blood. ,vol. 96, pp. 2226- 2232 ,(2000) , 10.1182/BLOOD.V96.6.2226
Stephen P. Goff, Pang-Dian Fan, Feng Cong, Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1. Cancer Research. ,vol. 63, pp. 873- 877 ,(2003)
Mei Dong, Gerard C. Blobe, Role of transforming growth factor-β in hematologic malignancies Blood. ,vol. 107, pp. 4589- 4596 ,(2006) , 10.1182/BLOOD-2005-10-4169